Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIRLANE: Ipatasertib + Paclitaxel in Early TNBC
NCT02301988Phase 2Completed
- Sponsor
- Genentech
- Start
- Feb 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of ipatasertib in triple-negative breast cancer (TNBC), sponsored by Genentech. Started Feb 2015; status: completed.
02
Drugs
ipatasertib
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02301988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301988.